Raphael Blum

Raphael Blum is a seasoned executive with extensive experience in oncology and global commercial development. Currently serving as Vice President and Head of Oncology at AbbVie since 2017, Raphael leads the therapeutic area strategy and global launch for oncology products. Previously, Raphael held significant roles at EMD Serono, Inc. and Pfizer, where responsibilities included strategic marketing for the Asia Pacific region and global commercial leadership for multi-billion dollar oncology franchises. Raphael's expertise encompasses product portfolio expansion, cross-functional team leadership, and successful product launches across various markets. The academic background includes a Master’s degree in Public Policy & Administration from Tel Aviv University and a Bachelor of Pharmacy from The Hebrew University of Jerusalem.